AZILECT Reviews

Average Rating: 3.0 (4 Ratings)

Filter Results

Compare AZILECT with similar:

 Type: Rx Drug
  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR AZILECTCOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 3  Parkinson's Good even got some smell back that I had lost years ago but managing medications when it interacts with so many other medications is difficult M 68 1 days
1
11/24/2015
 5  Young Onset Parkinson's Dry mouth, some dizziness. Since taking Azilect my tremors and muscle stiffness have not worsened. It's set a floor under the progress of the disease for now. My biggest concerns with this drug focus on the interaction risks (see drugs.com for the lengthy list), including mandatory avoidance of pseudoephedrine, other cold medicines, and general anesthesia. M 46 2 years
1 mg 1X D
8/24/2011
Email
 2  Parkinsons None I'm taking Azilect with Mirapex and Sinemet so don't know if it works or not. My insurance changed and now this drug costs over $300 a month. Just can't afford it since there is no generic. M 59 6 months
0.5 mg 1X D
2/19/2011
 2  Young Onset Parkinson's No side effects It just didn't work for me. No relief from sympyoms. My PD symptoms have continued to worsen, albeit at a very slow pace. M 45 12 months
1 mg 1X D
11/21/2010
  

AZILECT  (RASAGILINE MESYLATE):  Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Rasagiline belongs to a class of drugs known as MAO inhibitors. It works by increasing the levels of certain natural substances in the brain (such as dopamine, norepinephrine, serotonin). Parkinson's disease is thought to be caused by too little dopamine in the brain.   (Sources: U.S. Centers for Medicare Services, FDA)

BACK TO TOP